Non-linear dimensionality reduction on extracellular waveforms reveals cell type diversity in premotor cortex
Abstract
Cortical circuits are thought to contain a large number of cell types that coordinate to produce behavior. Current in vivo methods rely on clustering of specified features of extracellular waveforms to identify putative cell types, but these capture only a small amount of variation. Here, we develop a new method (WaveMAP) that combines non-linear dimensionality reduction with graph clustering to identify putative cell types. We apply WaveMAP to extracellular waveforms recorded from dorsal premotor cortex of macaque monkeys performing a decision-making task. Using WaveMAP, we robustly establish eight waveform clusters and show that these clusters recapitulate previously identified narrow- and broad-spiking types while revealing previously unknown diversity within these subtypes. The eight clusters exhibited distinct laminar distributions, characteristic firing rate patterns, and decision-related dynamics. Such insights were weaker when using featurebased approaches. WaveMAP therefore provides a more nuanced understanding of the dynamics of cell types in cortical circuits.
Data availability
Data generated or analysed during this study are included in the linked Dryad repository (doi:10.5061/dryad.z612jm6cf). Source data for all figures are also in this zip file.
-
WaveMAP analysis of extracellular waveforms from monkey premotor cortex during decision-makinghttps://creativecommons.org/publicdomain/zero/1.0/.
Article and author information
Author details
Funding
National Institute of Neurological Disorders and Stroke (R00NS092972)
- Chandramouli Chandrasekaran
National Institute on Deafness and Other Communication Disorders (DC017844)
- Krishna V Shenoy
National Institute of Neurological Disorders and Stroke (NS095548)
- Krishna V Shenoy
National Institute of Neurological Disorders and Stroke (NS098968)
- Krishna V Shenoy
Defense Advanced Research Projects Agency (N66001-10-C-2010)
- Krishna V Shenoy
Defense Advanced Research Projects Agency (W911NF-14-2-0013)
- Krishna V Shenoy
Simons Foundation (325380)
- Krishna V Shenoy
Simons Foundation (543045)
- Krishna V Shenoy
National Institute of Neurological Disorders and Stroke (122969)
- Chandramouli Chandrasekaran
Office of Naval Research (N000141812158)
- Krishna V Shenoy
Larry and Pamela Garlick
- Krishna V Shenoy
National Institute of Neurological Disorders and Stroke (K99NS092972)
- Chandramouli Chandrasekaran
Wu Tsai Neurosciences Institute, Stanford University
- Krishna V Shenoy
Hong Seh and Vivian H Lim Endowed Professorship
- Krishna V Shenoy
Howard Hughes Medical Institute
- Krishna V Shenoy
National Institute of Mental Health (R00MH101234)
- Maria Medalla
National Institute of Mental Health (R01MH116008)
- Maria Medalla
Whitehall Foundation (2019-12-77)
- Chandramouli Chandrasekaran
Brain and Behavior Research Foundation (27923)
- Chandramouli Chandrasekaran
NIH Office of the Director (DP1HD075623)
- Krishna V Shenoy
National Institute on Deafness and Other Communication Disorders (DC014034)
- Krishna V Shenoy
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Emilio Salinas, Wake Forest School of Medicine, United States
Ethics
Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the procedures were approved were approved by the Stanford Administrative Panel on Laboratory Animal Care (APLAC, Protocol Number 8856, entitled "Cortical Processing of Arm Movements"). Surgical procedures were performed under anesthesia, and every effort was made to minimize suffering. Appropriate analgesia, pain relief, and antibiotics were administered to the animals when needed after surgical approval.
Version history
- Preprint posted: February 8, 2021 (view preprint)
- Received: February 12, 2021
- Accepted: August 4, 2021
- Accepted Manuscript published: August 6, 2021 (version 1)
- Accepted Manuscript updated: August 10, 2021 (version 2)
- Accepted Manuscript updated: August 12, 2021 (version 3)
- Version of Record published: September 20, 2021 (version 4)
Copyright
© 2021, Lee et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 5,577
- Page views
-
- 741
- Downloads
-
- 22
- Citations
Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.
-
- Medicine
- Neuroscience
In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.